Women well informed about breast cancer, yet lacking knowledge about current treatments

	Tweet

According to a new GfK Roper Public Affairs survey sponsored by CancerCare, a national nonprofit cancer support organization, while the majority (76 percent) of women surveyed said they know at least a fair amount about breast cancer, many remain unaware of the important recent progress made in treatment. Fewer than one out of four (23 percent) women ages 50-65 have heard of new therapies for breast cancer, revealing a gap between awareness and information that women can use toward better treatment.

“These survey results suggest that many women still lack essential disease treatment information, which reinforces the need for women to educate themselves to help get the best treatment,” said Diane Blum, MSW, executive director of CancerCare. “While great progress has been made in breast cancer awareness through public education and increased media coverage, women with breast cancer would benefit from more information about advances in treatments after surgery.”

According to the survey, nearly all respondents were aware of chemotherapy and radiation. However, fewer than one out of four had heard of newer therapies such as aromatase inhibitors or monoclonal antibodies, nor were they informed about their benefits.

Doctor-patient dialogue is vital

If diagnosed, the majority of respondents said they would actively work with their doctor to identify the proper treatment. The survey also found that 71 percent of women would research the condition on their own in addition to discussing treatment options with their doctor. However, 86 percent were not certain they would know what questions to ask.

“Communication between the patients and their physicians is so important because it empowers them to take an active role in their treatment decisions,” explained Gary Frenette, MD PhD Medical Oncologist with Carolinas Medical Center. “With essential information, patients can work with their physicians to achieve the best possible outcomes in the management of their diagnosis.”

Key questions

Today, many women want to take an active role in participating in their treatment. CancerCare recommends that women consider the following questions to better prepare them should they face a breast cancer diagnosis:

* What kind of breast cancer do I have”
* Which treatments are available to me”
* What are the risks and benefits of those treatments”
* What is my risk that my breast cancer will come back and/or spread to another part of my body”
* Where do I go for support when I need it”

###

Contact: Christin Culotta

212-715-1621
Ruder Finn Public Relations

RELATED STORIES:
Light reveals breast tumor oxygen status   Study identifies women with breast cancer most likely to benefit from aromatase inhibitor   Weight change may also change breast cancer risk   COX-2 expression is marker for cancer development in some benign breast biopsies   Suspicion Lingers Over Bisphenol A and Breast Cancer   Gene therapy kills breast cancer stem cells, boosts chemotherapy   Contralateral Prophylactic Mastectomy Associated with Survival in Select Group of Breast Cancer   Peptide Delivers One-Two Punch to Breast Cancer in Pre-Clinical Study   Residual fetal cells in women may provide protection against breast cancer   No long-term cancer risk seen from breast implants   Scientists Break Genetic Code for Estrogen-Positive Breast Cancer   New tool predicts women’s outcome in breast cancer   Computer-Aided Detection Improves Early Breast Cancer Detection   Popular new breast cancer treatment lacks data   Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use   Active Lifestyle Reduces Risk of Invasive Breast Cancer   Breast Cancer Diagnostic Delay Depended More on Race/Ethnicity than Insurance   Breast density may increase cancer risk   Smoking Did Not Influence Breast Cancer Risk Among Obese Women   Cell of Origin Identified for Common Type of Breast Cancer   MSU study finds media coverage of breast cancer focuses too little on prevention   Suspicion Lingers Over Bisphenol A and Breast Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]